Atrial fibrillation in cancer: thromboembolism and bleeding in daily practice.

ABSTRACT:

Background

Cancer is suggested to confer thromboembolic and bleeding risk in patients with atrial fibrillation (AF).

Objectives

We aimed to describe current anticoagulant practice in patients with AF and active cancer, present incidences of thromboembolic and bleeding complications, and evaluate the association between cancer type or anticoagulant management strategy with AF-related complications.

Methods

This retrospective study identified patients with AF and active cancer in 2 hospitals between January 1, 2012, and December 31, 2017. Follow-up lasted for 2 years. Data on cancer and anticoagulant treatment were collected. The outcomes of interest included ischemic stroke or transient ischemic attack (TIA) and clinically relevant nonmajor bleeding (CRNMB/MB). Inciden

SUBMITTER: Chu G 

PROVIDER: S-EPMC10099322 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature